Cargando…

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic

Detalles Bibliográficos
Autores principales:	Simonini, G, Taddio, A, Cattalini, M, Caputo, R, DeLibero, C, Pagnini, I, Naviglio, S, Lepore, L, Cimaz, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194581/ http://dx.doi.org/10.1186/1546-0096-9-S1-P220

Ejemplares similares

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2013)

Predictors of relapse after discontinuing systemic treatment in autoimmune chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2014)

Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
por: Giani, TG, et al.
Publicado: (2008)

Childhood chronic anterior uveitis associated with vernal keratoconjunctivitis (VKC): successful treatment with topical tacrolimus. Case series
por: Taddio, Andrea, et al.
Publicado: (2011)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
por: Moretti, D, et al.
Publicado: (2013)

A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis
por: Rusche, Hendrik, et al.
Publicado: (2021)

Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience
por: Maccora, Ilaria, et al.
Publicado: (2022)

Non-anti TNF biologic modifier drugs in non-infectious refractory chronic uveitis: the current evidence from a systematic review
por: Simonini, Gabriele, et al.
Publicado: (2014)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Current evidence of MTX efficacy in childhood chronic uveitis: a systematic review and meta-analysis
por: Simonini, G, et al.
Publicado: (2011)

Laser Flare Photometry to Monitor Childhood Chronic Uveitis: A Preliminary Report of a Monocentric Italian Experience
por: Maccora, Ilaria, et al.
Publicado: (2023)

First results of the uveitis outcome study of the multinational interdisciplinary working group for uveitis in childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2014)

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
por: Erckens, R. J., et al.
Publicado: (2011)

PReS-FINAL-2347: Does switching anti-TNFΑ biologic agents an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach
por: Simonini, G, et al.
Publicado: (2013)

Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
por: García-De-Vicuña, Carmen, et al.
Publicado: (2013)

PReS-FINAL-2211: NOD2/CARD15 polymorphisms and clinical features in patients with non-infectious uveitis
por: Marrani, E, et al.
Publicado: (2013)

Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series
por: La Torre, Francesco, et al.
Publicado: (2014)

The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study
por: Marrani, E., et al.
Publicado: (2015)

Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
por: Vougiouka, O, et al.
Publicado: (2011)

Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2019)

“Brucellupus” in a boy: challenging sle diagnosis in childhood
por: Paganelli, Valeria, et al.
Publicado: (2014)

Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2020)

Psoriatic Juvenile Idiopathic Arthritis Associated with Uveitis: A Case Report
por: Moretti, Davide, et al.
Publicado: (2013)

Secondary prophylaxis in rheumatic fever: is it time to change?
por: Taddio, Andrea, et al.
Publicado: (2015)

PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis
por: Pagnini, I, et al.
Publicado: (2013)

Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics
por: Cattalini, Marco, et al.
Publicado: (2021)

Profile of adalimumab and its potential in the treatment of uveitis
por: Balevic, Stephen J, et al.
Publicado: (2016)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

When flexibility is not necessarily a virtue: a review of hypermobility syndromes and chronic or recurrent musculoskeletal pain in children
por: Cattalini, Marco, et al.
Publicado: (2015)

Uveitis in sporadic Blau syndrome: Long-term follow-up of a refractory case treated successfully with adalimumab
por: Naik, Anmol U, et al.
Publicado: (2018)

Outcome of adalimumab monotherapy in paediatric non-infectious uveitis
por: Al-Julandani, DA, et al.
Publicado: (2023)

PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
por: Vatta, P, et al.
Publicado: (2013)

Cutaneous PAN and Common Variable Immunodeficiency: what causes what?
por: Pagnini, Ilaria, et al.
Publicado: (2011)

Intraocular Inflammation Control and Changes in Retinal and Choroidal Architecture in Refractory Non-Infectious Uveitis Patients after Adalimumab Therapy
por: Pirani, Vittorio, et al.
Publicado: (2020)

Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry
por: Vitale, Antonio, et al.
Publicado: (2023)

Effectiveness of adalimumab in the treatment of juvenile idiopathic arthritis associated with uveitis
por: Zholobova, Elena, et al.
Publicado: (2014)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
por: Lanz, Sofia, et al.
Publicado: (2021)

Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis
por: Mase, Oliver, et al.
Publicado: (2023)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
por: Joos, R, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ibvlpkfnlq84uhmts6r2nfaik8